GlassScriptPhysician profile
Charles W Butrick
NPI 1295737633
$96,727.99
in general payments reported to CMS, 2019-2025
19 companies · $15.46 in 2025
The $15.46 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,074 · 2020: $2,999 · 2021: $2,206 · 2022: $2,689 · 2023: $22K · 2024: $66K · 2025: $15.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $86K · Travel and Lodging: $1,496 · Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $85,547.02 |
| Travel and Lodging | $1,495.95 |
| Food and Beverage | $716.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $93,857.87 | 2020-2024 | Axonics, Bulkamid |
| Abbott Laboratories | $360.85 | 2019-2023 | Proclaim |
| Astellas Pharma US INC | $308.60 | 2019-2022 | |
| Medtronic USA, INC. | $307.96 | 2019 | |
| Caldera Medical, INC | $273.08 | 2020-2022 | |
| Pfizer INC. | $264.20 | 2019-2022 | |
| Abbvie INC. | $246.42 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $235.72 | 2023-2024 | Gemtesa |
| Boston Scientific Corporation | $213.55 | 2019-2024 | Advantage System |
| Allergan, INC. | $155.39 | 2019-2021 | |
| Coloplast Corp | $141.01 | 2019-2021 | |
| Valencia Technologies Corporation | $121.81 | 2022 | |
| Antares Pharma, INC. | $55.26 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $53.34 | 2021-2022 | |
| Therapeuticsmd, INC. | $42.98 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $26.45 | 2022 | |
| Urovant Sciences INC | $25.09 | 2021-2022 | |
| Rochester Medical Corporation | $21.59 | 2021 | |
| Mission Pharmacal Company | $16.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Butrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.